Aug 28, 2018
A drug referred to as ospemifene can enhance genital tissue and sexual perform in postmenopausal girls, in accordance to new analysis in Sexual Medicine.
The drug, marketed underneath the model title Osphena, was permitted by the U.S. Food and Drug Administration (FDA) in 2013 to deal with reasonable to extreme dyspareunia – painful intercourse – in girls previous menopause.
Painful intercourse is a typical drawback after menopause. Estrogen is crucial for retaining the vagina moist and versatile. Production of this hormone declines dramatically at menopause, and many ladies expertise vaginal dryness and sexual discomfort because of this.
Ospemifene works like estrogen, restoring vaginal tissues.